MedX Health signs marketing agreement with MMB GmbH

MedX Health Corp., (TSXV.MDX) a global leader in developing drug free, non-invasive, low level laser and light therapy for tissue repair and pain relief, today announced that the company will be expanding its sales and marketing efforts with the new European master distributor MMB GmbH.

Earlier in 2009 MedX Health had announced the establishment of its first European Distribution Center in the Netherlands. The new partner company MMB (Medical Marketing Berlin GmbH) is located in the capital of the biggest European health care market (Germany) and focused on marketing and sales of the MedX Health Laser therapy products. Frank Raymakers, head of the MedX Health Distribution Center in the Netherlands, is the new European Sales Director at MMB GmbH. In the last several weeks he has successfully introduced the MedX Health Laser therapy products to various distributors in Europe.

The MMB GmbH is focused on serving the sales and marketing needs of North American health care companies and their market entry to Europe. The President, Mr. Andy Roesch, started his first medical device company in 1990 and introduced diverse medical products from North America in Germany and Europe. In the year 2000 his Roesch AG introduced to Europe the needle and pain free injection device, called Injex and later took the company with huge success onto the Frankfurt Stock Exchange.

"We completed extensive due diligence and market studies on the MedX Health product technology. We see excellent market opportunities in Europe and we are excited to present for the first time with MedX Health at the MEDICA 2009 in Dusseldorf in Germany" stated Andy Roesch.

"We made a strong commitment to globalize our laser and light products, and we are well on our way with our new partner in Berlin, obtaining CE Mark for all laser and light products, and rapidly expanding our worldwide network of new distributors," states Steve Guillen, President and CEO of MedX Health.



The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
Study shows vaccinated multiple myeloma patients at greater risk of breakthrough SARS-CoV-2 infections